Development and validation of blood-based predictive biomarkers for response to PD-(L)-1 checkpoint inhibitors.
MedRxiv |
Cancer
PSE boosts PSA accuracy from 55% to 94% for confirming the presence or absence of prostate cancer. The highly accurate blood test is simple to order by a physician and is available to men in the US and UK under the immediate access program.
Cancer
Infectious disease
Neuro/CNS
Infectious disease
Cancer
Neuro/CNS